Responses
Late-breaking abstracts
Biomarkers, immune monitoring, and novel technologies
757 Intratumoral delivery CD40 agonist antibody via novel nanofluidic drug-eluting seed reduced tumor burden of murine pancreatic ductal adenocarcinoma
Compose a Response to This Article
Other responses
No responses have been published for this article.
